TNF and acute myeloid leukemia: Furthermore, Th17 cells in ND AML patients (34.11 ± 9.04%) maintained higher levels of TNF-α expression as compared with Th17 subsets in healthy controls (26.12 ± 8.62%, P < 0.05) and CR patients (21.68 ± 6.41%, P < 0.05) (Figure 3E).